AHAG yields 2000000.00% · JNJ yields 2.13%● Live data
📍 AHAG pulled ahead of the other in Year 1
Combined, AHAG + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AHAG + JNJ for your $10,000?
Alpha Technologies Group, Inc., through its subsidiaries, manufactures, fabricates, and sells thermal management and non-thermal fabricated products, and aluminum extrusions in the United States. It offers natural convection products, which include thermal extrusions, board level and BGA heatsinks, LED heat sinks, folded fins, bonded and stacked fins, and heat frames; forced convection products, such as skived and zipper fins, and fans; fluid phase change products, including heat pipes; and liquid cooling products, such as liquid cold plates, heat exchangers, and coolant distribution units. The company also provides accessories, such as wedgelocks, front panels, enclosures, precision clamps, thermal interface material, and data center cooling accessories; and universal joints, which include alves blue blocks, solid blocks, hex blocks, double universal joints, needle bearings, and universal joint accessories. In addition, it offers engineering, such as applications engineering and design services; manufacturing, which include extrusion, fabrication, machining services, and quick turn prototyping; supply chain services; and data center cooling services. It serves aerospace/defense, architecture, power conversion, information tech, renewable energy, telecommunications, led lighting, factory automation, consumer, medical, and transportation industries; and construction, sporting goods, and other leisure activity markets. Alpha Technologies Group, Inc. was formerly known as Synercom Technology, Inc. and changed its name to Alpha Technologies Group, Inc. in 1995. The company was founded in 1969 and is based in Los Angeles, California.
Full AHAG Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.